OBOlga Valentinovna Bochkarnikova

Olga Valentinovna Bochkarnikova

*This is an algorithmically generated author record based on publicly available information.

Olga Valentinovna Bochkarnikova has a total of 40 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Observation of combination of three malignant neoplasms of the stomach with underlying chronic autoimmune gastritis: MALT lymphoma, diffuse large B‑cell lymphoma and well‑differentiated neuroendocrine tumor

    by Z. O. Krishtal, A. S. Zanozin, A. S. Tertychnyy, O. V. Bochkarnikova, K. I. Alekseev

    Chronic autoimmune gastritis diagnosed primarily in women after 60 years of age increases the risk of neuroendocrine tumors to 0.4–0.7 % per year. Presence of chronic inflammatory process in the gastric wall can serve as a predictor of the most common gastric extranodal marginal zone lymphoma, or mucosa-associated lymphoid tissue (MALT) lymphoma which in 20 % of cases transforms into large B-cell lymphoma. The article presents an observation of a rare combination of well-differentiated neuroendocrine tumor of the stomach, gastric MALT lymphoma and large B-cell lymphoma developed in a 67-year-old female patient with chronic autoimmune gastritis. Histological examination showed growth of well-differentiated neuroendocrine tumor with low mitotic activity. In the lamina propria, including marginal zone of reactive lymphatic follicles, infiltrate consisting of centrocyte-like small and intermediate sized cells with signs of lymphoepithelial involvement and extension into the lamina muscularis and submucosa were observed. Morphological picture corresponded to MALT lymphoma. Additionally, proliferation of medium and large lymphocyte-like cells with vesicular nuclei, several nucleoli at the periphery of the nucleus, of moderate volume, with amphiphilic and basophilic cytoplasm and high mitotic activity was found in the submucosa and lamina propria. Morphological picture corresponded to growth of diffuse large B-cell lymphoma in the mucosa and submucosa. Specific feature of our clinical observation was a rare combination in one patient of 3 malignant tumors of the same site: neuroendocrine tumor, extranodal marginal zone lymphoma and diffuse large B-cell lymphoma. On one hand, development of neuroendocrine tumor was associated with hyperplasia of G cells in autoimmune gastritis; on the other hand, development of MALT lymphoma and diffuse large B-cell lymphoma was associated with antigen-independent tumor transformation with further clonal evolution.

  • Open Access

    Simultaneous tumors: ovarian cancer in a patient with multiple myeloma

    by Igor Yu. Gadaev, Irina V. Gadaeva, Kseniya A. Rossolovskaya, Olga V. Bochkarnikova, Irina Yakovlevna Sokolova, Россоловская Ксения Антоновна

    Multiple myeloma is the second most common hematological malignancy, accounting for approximately 1% and 10–15% of malignant tumors of the hematopoietic and lymphoid systems, respectively. Until recently, the diagnosis of multiple myeloma was inherently associated with unfavorable prognosis of overall survival. On the one hand, advanced diagnosis techniques and the development of new treatment approaches have led to the improved life expectancy and significant reduction of mortality of patients with multiple myeloma. On the other hand, the medical and research communities have encountered a previously unknown issue: the combination of multiple myeloma with other types of cancer. This combination sets a task of multidisciplinary approach in the diagnosis and requires development of patient management strategy and prognostic parameters of the outcome. Some researchers adhere to the theory of independent tumor appearance in patients suffering from multiple myeloma, while other authors suppose that multiple myeloma and secondary cancer virtually represent multiple primary malignant neoplasms. This article presents a clinical case of postmortem verification of ovarian cancer in a patient with recurrent multiple myeloma.

  • Study of proinflammatory markers, galectin-3 level, lipid metabolism parameters, cardiovascular status and their relationship in patients with lymphomas before antitumor therapy

    by I. Ya. Sokolova, S. A. Kardovskaya, E. Yu. Salakheeva, Yu. Yu. Kirichenko, E. A. Siderko, O. V. Bochkarnikova, A. A. Shchendrygina, Yu. N. Belenkov, I. S. Ilgisonis

  • Open Access

    Study of proinflammatory markers, galectin-3 level, lipid metabolism parameters, cardiovascular status and their relationship in patients with lymphomas before antitumor therapy

    by I. Ya. Sokolova, S. A. Kardovskaya, E. Yu. Salakheeva, Yu. Yu. Kirichenko, E. A. Siderko, O. V. Bochkarnikova, A. A. Shchendrygina, Yu. N. Belenkov, И. С. Ильгисонис, Ю. Ю. Кириченко

    Изучение провоспалительных маркеров, уровня галектина-3, параметров липидного обмена, сердечно-сосудистого статуса и их взаимосвязей у пациентов с лимфомами до начала противоопухолевой терапии

  • Changes in the lipid profile, structural and functional states of blood vessels in patients with lymphomas and cardiovascular toxic risks during the chemotherapy

    by R.R. Karimov, O.V. Bochkarnikova, D.A. Budanova, Yu.N. Belenkov, I.S. Ilgisonis

    The use of polychemotherapy (PCT) in individual oncological patients causes complications, of which results of impact on cardiovascular system are the most severe. Objective. To assess the dynamics and interrelation of lipid profile parameters, structural-functional (SF) indicators of arterial vessels condition in patients with lymphomas and different severity of cardiovasculotoxic (CVT) risk in addition to PCT courses, containing anthracycline antibiotics (AA). Material and methods. The study included 40 patients with new-onset lymphoproliferative disease. All patients were divided into 2 groups depending on the initial CVT risk: the 1st group (n=20) — low/intermediate CVT risk; the 2nd group (n=20) — high/very high CVT risk. All patients underwent laboratory and instrumental examination before and after the three courses of PCT containing AA, including the determination of lipid levels and parameters of SF vessels condition. Non-invasive methods were used to assess the SF condition of vessels: finger photoplethysmography (PPG) and computer videocapillaroscopy (CVC). Results. A statistically significant increase in total cholesterol (TC), low-density lipoproteins, very-low-density lipoproteins and triglycerides levels have been revealed in patients of the 1st group after three courses of AA-containing PCT. Patients of the 2nd group have shown statistically significant increase only in TC level. According to PPG and CVC data, progression of SF disorders at all levels of the vascular bed has been noted in patients of both groups. Nevertheless, SF disorders were less pronounced in patients of the 2nd group. Conclusion. There is an initial endothelial dysfunction in patients with lymphoproliferative disease, which is progressively worsening with polychemotherapy, mostly in patients without cardioprotective therapy. The progression of endothelial dysfunction, increase in the level of proatherogenic lipids and their relationship with the course of polychemotherapy containing anthracycline antibiotics may indicate the development of early asymptomatic vasculotoxicity when applying this group of drugs. Further studies on a larger sample of patients are needed.

  • Study of the initial vasculotoxic risk in patients with lymphoproliferative diseases before the start of polychemotherapy

    by R. R. Karimov, E. Yu. Salakheeva, D. A. Budanova, O. N. Antyufeeva, O. V. Bochkarnikova, E. V. Privalova, Yu. N. Belenkov, И. С. Ильгисонис

    Research objective. To evaluate the levels of CRP, cardio-specific markers, lipids, structural-functional (SF) state of vessels, and their interrelations in patients with lymphoproliterative diseases (LPD) before polychemotherapy (PCT).Materials and methods. The study included patients with newly diagnosed LPD (n = 30), including 16 men (53.3%) and 14 women (46.7%). All patients were divided into two groups: group 1 (n = 15) — patients with low/intermediate cardiovascular toxicity (CVT) risk; group 2 (n = 15) — patients with high/very high CVT risk. CVT risk stratification was performed with the use of specialized scales according to the current European clinical guidelines for cardio-oncology 2022. All patients included in the study underwent standard laboratory and instrumental examinations. Specific laboratory research involved assessing the levels of C-reactive protein (CRP), troponin I (TnI), N-terminal pro-brain natriuretic peptide (NT-proBNP), and lipid profile. The SF state of vessels was evaluated non-invasively using photoplethysmography (PPG) (Angioscan-01 device, Russia) and computerized videocapillaroscopy (CVC) of the periungual area (Capillaroscan-01 device, Russia).Results. According to the results of PPG and CVC, the occlusion index (OI) in group 2 was significantly lower and amounted to 1.2 [1; 1.3] compared to 1.7 [1.45; 2.1] in group 1 (p < 0.001); capillary density after reactive hyperemia (CDRH) was also significantly lower in group 2 compared to group 1 — 43 [35.5; 45] and 54 [43; 58] cap/mm², respectively (p = 0.033). According to the obtained results, there were no statistically significant diff erences in the levels of CRP, TnI, and NT-proBNP between patients in both groups; the indicators were within the reference values. A moderate inverse statistically signifi cant correlation was found between the level of CRP and the percentage of perfused capillaries (PPC) (rs = –0.545; p = 0.02) and the percentage of capillary recovery (PCR) (r = –0.446; p = 0.013).Conclusion. Patients with LPD have endothelial dysfunction before PCT, primarily due to the presence of cardiovascular risk factors (age, body mass index), and concomitant cardiovascular diseases. At the same time, the SF state of vessels initially does not depend on the stage and course of LPD, lipid levels, and TnI.


  • Open Access

    Successful Implementation of Combined Treatment Methods for a Rare Recurrence of Waldenstrom Macroglobulinemia With Extramedullary Lesions

    by Irina Yakovlevna Sokolova, Sabina Maximovna Sokolova, Olga Valentinovna Bochkarnikova, Ayshat Eldarovna Rasulova, Timur Raisovich Izmailov, Pavel Vladimirovich Polushkin, Yulia Yurevna Kirichenko, Yuriy Nikitich Belenkov, Irina Sergeevna Ilgisonis

    Successful Implementation of Combined Treatment Methods for a Rare Recurrence of Waldenstrom Macroglobulinemia With Extramedullary Lesions

  • Open Access

    Vasculotoxicity of anthracycline antibiotics: the current state of the problem

    by R.R. Karimov, O.V. Bochkarnikova, N.V. Khabarova, Yu.N. Belenkov, I.S. Ilgisonis

    Васкулотоксичность антрациклиновых антибиотиков: современное состояние проблемы


  • Open Access

    Assessment of systemic inflammation activity, myocardial structure and functional features, their relationship in patients with multiple myeloma, receiving bortezomib therapy

    by E. V. Fomina, S. A. Kardanova, O. V. Bochkarnikova, Sh. M. Murtuzaliev, S. A. Appolonova, P. A. Markin, E. V. Privalova, I. S. Ilgisonis, Yu. N. Belenkov

    Aim. To study the dynamics of calculated indices [neutrophil-lymphocyte ratio (NLR); systemic inflammation index (SIV)] and biomarkers of systemic inflammation [interleukin-1β (IL-1β); high-sensitivity C-reactive protein (hsCRP)], parameters of the structure-and-function state of the myocardium and intracardiac hemodynamics, and their relationship in patients newly diagnosed with multiple myeloma (MM) at the onset of the disease and after 6 courses of chemotherapy (CT) containing the proteasome inhibitor bortezomib. Material and methods. This prospective study included 30 patients aged 63.8±10.0 years diagnosed with MM; 17 (56.7 %) of them were men. The following tests were performed for all patients: measurement of IL-1β and hsCRP, calculation of the inflammation indexes NLR and SIV, transthoracic echocardiography before and after 6 courses of bortezomib-containing CT. At the time of study completion, 9 patients dropped out due to reasons not related to cardiovascular complications of CT. Results. The antitumor therapy was associated with increases of immune-inflammation indexes: NLR increased from 1.54 [1.02; 1.83] to 2.9 [1.9; 4.35] (p=0.009) and SIV increased from 402.95 [230.5; 534.0] to 1102.2 [453.1; 1307.9] (р=0.014). IL-1β increased from 5.15 [4.05; 5.77] to 6.22 [5.66; 6.52] pg/ml remaining within the reference range (p=0.142) whereas hsCRP decreased from 1.02 [0.02; 2.71] to 0.02 [0.02; 0.82] IU/l (p=0.138). Statistically significant changes in parameters of heart remodeling and clinical picture of cardiovascular complications were not observed. A correlation analysis showed significant inverse correlations of hsCRP with left ventricular ejection fraction (LV EF) (r= –0.557; p=0.003), the number of plasma cells (PC) with LV EF (r= –0.443; p=0.023), and a direct correlation of the number of PC with hsCRP (r=0.433; p=0.022). Conclusion. During the study, the accepted criteria for cardiotoxicity of bortezomib-containing chemotherapy in patients with MM, were not met. The identified correlations between the level of markers for acute inflammation, indexes of intracardiac hemodynamics, and the immediate MM substrate may indicate the role of chronic low-intensity inflammation in the pathogenesis of myocardial remodeling in patients with MM. This necessitates further studies on larger samples of patients to assess the prognostic significance.